Eris Lifesciences to Increase Its Stake in Swiss Parenterals
Eris Lifesciences has announced plans to consolidate its stake in Swiss Parenterals, while bringing Naishadh Shah on board as a top-10 shareholder and part of the management, strengthening its leadership and long-term strategic vision.
Pharma Acquisitions | 27/11/2025 | By Dineshwori | 115
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy